Symbols / NBTX
NBTX Chart
About
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.29B |
| Enterprise Value | 1.24B | Income | -51.64M | Sales | 10.16M |
| Book/sh | -1.70 | Cash/sh | 0.60 | Dividend Yield | — |
| Payout | 0.00% | Employees | 103 | IPO | — |
| P/E | — | Forward P/E | 83.72 | PEG | — |
| P/S | 126.56 | P/B | -15.66 | P/C | — |
| EV/EBITDA | -28.38 | EV/Sales | 122.47 | Quick Ratio | 0.58 |
| Current Ratio | 0.63 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -1.29 | EPS next Y | 0.32 | EPS Growth | — |
| Revenue Growth | 186.80% | Earnings | 2026-03-31 | ROA | -41.64% |
| ROE | — | ROIC | — | Gross Margin | 100.00% |
| Oper. Margin | 3.06% | Profit Margin | 0.00% | Shs Outstand | 48.39M |
| Shs Float | 30.92M | Short Float | 0.08% | Short Ratio | 1.02 |
| Short Interest | — | 52W High | 30.35 | 52W Low | 2.95 |
| Beta | 0.41 | Avg Volume | 35.20K | Volume | 32.23K |
| Target Price | $27.87 | Recom | Strong_buy | Prev Close | $25.72 |
| Price | $26.57 | Change | 3.31% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$27.87
Mean price target
2. Current target
$26.57
Latest analyst target
3. DCF / Fair value
$-6.42
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$26.57
Low
$25.53
High
$33.18
Mean
$27.87
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-06 | main | Guggenheim | Buy → Buy | $26 |
| 2025-04-04 | main | Guggenheim | Buy → Buy | $8 |
| 2024-08-28 | init | Guggenheim | — → Buy | $12 |
| 2023-12-08 | init | Leerink Partners | — → Outperform | $11 |
| 2021-01-06 | init | Evercore ISI Group | — → Outperform | — |
- Nanobiotix (NASDAQ:NBTX) Shares Gap Down - What's Next? - MarketBeat Wed, 11 Feb 2026 18
- symbol__ Stock Quote Price and Forecast - CNN Wed, 07 May 2025 07
- Is NBTX stock undervalued right now - 2025 Year in Review & Free Weekly Watchlist of Top Performers - mfd.ru Sat, 14 Feb 2026 15
- Nanobiotix S.A.: Behind The Recent Momentum (NASDAQ:NBTX) - Seeking Alpha hu, 23 Oct 2025 07
- Nanobiotix (NBTX) Sees Significant Price Target Increase by Gugg - GuruFocus Sat, 07 Feb 2026 04
- Nanobiotix (NASDAQ: NBTX) details €20.4M cash and 2026 clinical data outlook - Stock Titan Mon, 24 Nov 2025 08
- Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue - The Motley Fool Mon, 24 Nov 2025 08
- Price-Driven Insight from (NBTX) for Rule-Based Strategy - Stock Traders Daily Mon, 19 Jan 2026 05
- Insider Trends: Will NBTX stock recover after earnings - Weekly Stock Analysis & Capital Efficient Trade Techniques - baoquankhu1.vn hu, 12 Feb 2026 12
- Nanobiotix (NASDAQ:NBTX) Shares Gap Up After Analyst Upgrade - MarketBeat Mon, 09 Feb 2026 15
- Nanobiotix stock jumps on positive esophageal cancer treatment data - Investing.com hu, 02 Oct 2025 07
- Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case (NASDAQ:NBTX) - Seeking Alpha hu, 18 Sep 2025 07
- Why NBTX stock is a must watch in 2025 - July 2025 PostEarnings & Community Driven Trade Alerts - mfd.ru Mon, 16 Feb 2026 06
- Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat Sun, 08 Feb 2026 09
- How cyclical is NBTX’s revenue stream - Quarterly Market Summary & Weekly Return Optimization Alerts - mfd.ru Sat, 14 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 746.25K | -1.58M | 526.50K | 1.65M |
| TaxRateForCalcs | 0.25 | 0.25 | 0.25 | 0.27 |
| NormalizedEBITDA | -61.31M | -23.76M | -51.80M | -51.01M |
| TotalUnusualItems | 2.98M | -6.32M | 2.11M | 6.24M |
| TotalUnusualItemsExcludingGoodwill | 2.98M | -6.32M | 2.11M | 6.24M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -68.13M | -39.70M | -57.04M | -47.00M |
| ReconciledDepreciation | 1.62M | 1.51M | 1.50M | 1.56M |
| EBITDA | -58.32M | -30.09M | -49.70M | -44.77M |
| EBIT | -59.95M | -31.60M | -51.20M | -46.33M |
| NetInterestIncome | -2.62M | -6.48M | -12.44M | -658.00K |
| InterestExpense | 8.09M | 7.98M | 5.84M | 671.00K |
| InterestIncome | 2.63M | 1.22M | 256.00K | 0.00 |
| NormalizedIncome | -70.37M | -34.96M | -58.62M | -51.59M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -68.13M | -39.70M | -57.04M | -47.00M |
| TotalExpenses | 56.78M | 56.84M | 46.70M | 52.59M |
| RentExpenseSupplemental | 9.64M | |||
| TotalOperatingIncomeAsReported | -68.39M | -26.78M | -46.70M | -52.58M |
| DilutedAverageShares | 47.27M | 36.93M | 34.78M | 34.73M |
| BasicAverageShares | 47.27M | 36.93M | 34.78M | 34.73M |
| DilutedEPS | -1.44 | -1.08 | -1.64 | -1.35 |
| BasicEPS | -1.44 | -1.08 | -1.64 | -1.35 |
| DilutedNIAvailtoComStockholders | -68.13M | -39.70M | -57.04M | -47.00M |
| NetIncomeCommonStockholders | -68.13M | -39.70M | -57.04M | -47.00M |
| NetIncome | -68.13M | -39.70M | -57.04M | -47.00M |
| NetIncomeIncludingNoncontrollingInterests | -68.13M | -39.70M | -57.04M | -47.00M |
| NetIncomeContinuousOperations | -68.13M | -39.70M | -57.04M | -47.00M |
| TaxProvision | 101.00K | 120.00K | 10.00K | 5.00K |
| PretaxIncome | -68.03M | -39.58M | -57.03M | -47.00M |
| OtherIncomeExpense | 2.98M | -6.32M | 2.11M | 6.24M |
| SpecialIncomeCharges | 0.00 | 0.00 | 0.00 | |
| GainOnSaleOfSecurity | 2.98M | -6.32M | 2.11M | 6.24M |
| NetNonOperatingInterestIncomeExpense | -2.62M | -6.48M | -12.44M | -658.00K |
| TotalOtherFinanceCost | -2.83M | -285.00K | 6.86M | -13.00K |
| InterestExpenseNonOperating | 8.09M | 7.98M | 5.84M | 671.00K |
| InterestIncomeNonOperating | 2.63M | 1.22M | 256.00K | 0.00 |
| OperatingIncome | -68.39M | -26.78M | -46.70M | -52.58M |
| OperatingExpense | 56.78M | 56.84M | 46.70M | 52.59M |
| OtherOperatingExpenses | -837.00K | 448.00K | 343.00K | 5.27M |
| OtherTaxes | -3.30M | -3.94M | -4.09M | -2.49M |
| DepreciationAmortizationDepletionIncomeStatement | 319.00K | 270.00K | 335.00K | 416.00K |
| DepreciationAndAmortizationInIncomeStatement | 319.00K | 270.00K | 335.00K | 416.00K |
| Amortization | 1.00K | 0.00 | 1.00K | 10.00K |
| AmortizationOfIntangiblesIncomeStatement | 1.00K | 0.00 | 1.00K | 10.00K |
| DepreciationIncomeStatement | 318.00K | 270.00K | 334.00K | 406.00K |
| ResearchAndDevelopment | 40.54M | 38.40M | 32.64M | 30.38M |
| SellingGeneralAndAdministration | 20.06M | 21.66M | 17.48M | 19.02M |
| GeneralAndAdministrativeExpense | 20.06M | 21.66M | 17.48M | 19.02M |
| OtherGandA | 8.07M | 9.89M | 7.79M | 9.64M |
| RentAndLandingFees | 9.64M | |||
| SalariesAndWages | 11.99M | 11.77M | 9.69M | 9.38M |
| TotalRevenue | -11.61M | 30.06M | 0.00 | 10.00K |
| OperatingRevenue | -11.61M | 30.06M | 0.00 | 10.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 22.12K | 22.12K | 22.12K | 15.46K |
| OrdinarySharesNumber | 47.40M | 47.11M | 34.85M | 34.83M |
| ShareIssued | 47.43M | 47.13M | 34.88M | 34.84M |
| NetDebt | 6.25M | |||
| TotalDebt | 50.90M | 50.56M | 53.17M | 46.02M |
| TangibleBookValue | -65.71M | -1.85M | -27.05M | 26.79M |
| InvestedCapital | -19.03M | 43.64M | 20.59M | 66.29M |
| WorkingCapital | 2.53M | 37.47M | 14.42M | 56.22M |
| NetTangibleAssets | -65.71M | -1.85M | -27.05M | 26.79M |
| CapitalLeaseObligations | 4.23M | 5.08M | 5.53M | 6.52M |
| CommonStockEquity | -65.70M | -1.84M | -27.05M | 26.79M |
| TotalCapitalization | -22.69M | 39.82M | 17.00M | 59.21M |
| TotalEquityGrossMinorityInterest | -65.70M | -1.84M | -27.05M | 26.79M |
| StockholdersEquity | -65.70M | -1.84M | -27.05M | 26.79M |
| GainsLossesNotAffectingRetainedEarnings | -311.51M | -276.07M | -226.58M | -182.82M |
| OtherEquityAdjustments | -311.51M | -276.07M | -226.58M | -182.82M |
| TreasuryStock | 228.00K | 228.00K | 228.00K | 202.00K |
| RetainedEarnings | -68.13M | -39.70M | -57.04M | -47.00M |
| AdditionalPaidInCapital | 312.74M | 312.74M | 255.76M | 255.77M |
| CapitalStock | 1.42M | 1.41M | 1.05M | 1.04M |
| CommonStock | 1.42M | 1.41M | 1.05M | 1.04M |
| TotalLiabilitiesNetMinorityInterest | 133.12M | 95.74M | 86.81M | 74.98M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 74.19M | 45.87M | 48.88M | 38.13M |
| OtherNonCurrentLiabilities | 27.78M | 2.00K | -1.00K | |
| EmployeeBenefits | 432.00K | 323.00K | 270.00K | 318.00K |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 432.00K | 323.00K | 270.00K | 318.00K |
| LongTermDebtAndCapitalLeaseObligation | 45.98M | 45.54M | 48.61M | 37.82M |
| LongTermCapitalLeaseObligation | 2.97M | 3.88M | 4.57M | 5.39M |
| LongTermDebt | 43.01M | 41.66M | 44.04M | 32.42M |
| CurrentLiabilities | 58.94M | 49.87M | 37.94M | 36.84M |
| OtherCurrentLiabilities | 7.83M | |||
| CurrentDeferredLiabilities | 18.16M | 18.23M | 16.57M | 16.77M |
| CurrentDeferredRevenue | 18.16M | 18.23M | 16.57M | 16.77M |
| CurrentDebtAndCapitalLeaseObligation | 4.92M | 5.02M | 4.56M | 8.20M |
| CurrentCapitalLeaseObligation | 1.26M | 1.20M | 962.00K | 1.13M |
| CurrentDebt | 3.66M | 3.82M | 3.60M | 7.08M |
| OtherCurrentBorrowings | 3.66M | 3.82M | 3.60M | 7.08M |
| CurrentProvisions | 438.00K | 760.00K | 327.00K | 110.00K |
| PayablesAndAccruedExpenses | 27.58M | 25.86M | 16.48M | 11.76M |
| CurrentAccruedExpenses | 15.55M | 11.37M | 5.39M | 1.49M |
| Payables | 12.03M | 14.49M | 11.08M | 10.27M |
| OtherPayable | 672.00K | 420.00K | 488.00K | 199.00K |
| TotalTaxPayable | 6.87M | 7.38M | 6.59M | 5.08M |
| AccountsPayable | 4.48M | 6.70M | 4.00M | 5.00M |
| TotalAssets | 67.42M | 93.90M | 59.77M | 101.77M |
| TotalNonCurrentAssets | 5.95M | 6.56M | 7.41M | 8.71M |
| NonCurrentPrepaidAssets | 406.00K | 299.00K | 291.00K | 421.00K |
| InvestmentsAndAdvances | 0.00 | 0.00 | 98.00K | |
| InvestmentinFinancialAssets | 0.00 | 0.00 | 98.00K | |
| AvailableForSaleSecurities | 98.00K | |||
| GoodwillAndOtherIntangibleAssets | 7.00K | 8.00K | 1.00K | 4.00K |
| OtherIntangibleAssets | 7.00K | 8.00K | 1.00K | 4.00K |
| NetPPE | 5.54M | 6.25M | 7.12M | 8.19M |
| AccumulatedDepreciation | -11.02M | -9.46M | -8.18M | -6.83M |
| GrossPPE | 16.56M | 15.71M | 15.30M | 15.02M |
| ConstructionInProgress | 391.00K | 188.00K | 344.00K | 98.00K |
| OtherProperties | 2.49M | 2.33M | 2.13M | 2.14M |
| MachineryFurnitureEquipment | 4.65M | 4.40M | 4.37M | 4.39M |
| BuildingsAndImprovements | 9.03M | 8.80M | 8.46M | 8.39M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 61.47M | 87.34M | 52.36M | 93.06M |
| OtherCurrentAssets | -1.00K | 1.00K | 1.00K | |
| PrepaidAssets | 3.19M | 2.56M | 2.98M | 2.21M |
| Receivables | 8.54M | 9.49M | 7.99M | 6.93M |
| OtherReceivables | 1.08M | 3.48M | 2.74M | 3.38M |
| TaxesReceivable | 4.47M | 5.11M | 5.15M | 3.55M |
| AccountsReceivable | 2.98M | 905.00K | 101.00K | 0.00 |
| CashCashEquivalentsAndShortTermInvestments | 49.74M | 75.28M | 41.39M | 83.92M |
| CashAndCashEquivalents | 49.74M | 75.28M | 41.39M | 83.92M |
| CashEquivalents | 44.43M | 0.00 | 2.81M | |
| CashFinancial | 5.31M | 75.28M | 38.58M | 83.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -20.40M | -12.81M | -37.20M | -30.11M |
| RepaymentOfDebt | -4.16M | -3.77M | -4.74M | -3.74M |
| IssuanceOfDebt | 0.00 | 150.00K | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 60.15M | 0.00 | 0.00 |
| CapitalExpenditure | -848.00K | -337.00K | -93.00K | -233.00K |
| EndCashPosition | 49.74M | 75.28M | 41.39M | 83.92M |
| BeginningCashPosition | 75.28M | 41.39M | 83.92M | 119.15M |
| EffectOfExchangeRateChanges | 94.00K | -51.00K | 83.00K | 64.00K |
| ChangesInCash | -25.64M | 33.95M | -42.62M | -35.29M |
| FinancingCashFlow | -5.13M | 46.77M | -5.65M | -5.18M |
| CashFlowFromContinuingFinancingActivities | -5.13M | 46.77M | -5.65M | -5.18M |
| NetOtherFinancingCharges | -2.79M | -1.00K | -349.00K | |
| InterestPaidCFF | -980.00K | -6.98M | -915.00K | -1.13M |
| ProceedsFromStockOptionExercised | 0.00 | 0.00 | 43.00K | |
| CashDividendsPaid | 0.00 | 0.00 | 0.00 | 0.00 |
| NetCommonStockIssuance | 0.00 | 60.15M | 0.00 | 0.00 |
| CommonStockIssuance | 0.00 | 60.15M | 0.00 | 0.00 |
| NetIssuancePaymentsOfDebt | -4.16M | -3.62M | -4.74M | -3.74M |
| NetLongTermDebtIssuance | -4.16M | -3.62M | -4.74M | -3.74M |
| LongTermDebtPayments | -4.16M | -3.77M | -4.74M | -3.74M |
| LongTermDebtIssuance | 0.00 | 150.00K | 0.00 | 0.00 |
| InvestingCashFlow | -955.00K | -349.00K | 138.00K | -242.00K |
| CashFlowFromContinuingInvestingActivities | -955.00K | -349.00K | 137.00K | -242.00K |
| NetOtherInvestingChanges | 1.00K | |||
| NetInvestmentPurchaseAndSale | -107.00K | -12.00K | 230.00K | -9.00K |
| PurchaseOfInvestment | -9.00K | |||
| NetIntangiblesPurchaseAndSale | -2.00K | -9.00K | -1.00K | -5.00K |
| PurchaseOfIntangibles | -2.00K | -9.00K | -1.00K | -5.00K |
| NetPPEPurchaseAndSale | -846.00K | -328.00K | -92.00K | -228.00K |
| PurchaseOfPPE | -846.00K | -328.00K | -92.00K | -228.00K |
| OperatingCashFlow | -19.55M | -12.48M | -37.10M | -29.87M |
| CashFlowFromContinuingOperatingActivities | -19.55M | -12.48M | -37.10M | -29.87M |
| TaxesRefundPaid | -62.00K | -7.00K | 0.00 | 0.00 |
| ChangeInWorkingCapital | 14.28M | 9.92M | 2.30M | 11.54M |
| ChangeInOtherWorkingCapital | 12.19M | 1.61M | 16.52M | |
| ChangeInOtherCurrentLiabilities | -224.00K | 723.00K | 1.22M | -1.65M |
| ChangeInPayablesAndAccruedExpense | 1.96M | 8.68M | 2.90M | -281.00K |
| ChangeInPayable | 1.96M | 8.68M | 2.90M | -281.00K |
| ChangeInReceivables | 355.00K | -1.09M | -1.83M | -3.04M |
| ChangesInAccountReceivables | -2.07M | -806.00K | -101.00K | 62.00K |
| OtherNonCashItems | 28.61M | 11.97M | 12.66M | 678.00K |
| StockBasedCompensation | 4.30M | 3.22M | 3.17M | 3.20M |
| ProvisionandWriteOffofAssets | -263.00K | 506.00K | 305.00K | 152.00K |
| DeferredTax | 101.00K | 120.00K | 0.00 | 0.00 |
| DeferredIncomeTax | 101.00K | 120.00K | 0.00 | 0.00 |
| DepreciationAmortizationDepletion | 1.62M | 1.51M | 1.50M | 1.56M |
| DepreciationAndAmortization | 1.62M | 1.51M | 1.50M | 1.56M |
| OperatingGainsLosses | -3.00K | -24.00K | 3.00K | |
| NetIncomeFromContinuingOperations | -68.13M | -39.70M | -57.04M | -47.00M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for NBTX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|